Showing results (2141-2150 of 2,176) with videos related to
Sort By:
Pageof 218
Blood|March 16, 2025
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcomeChangya Chen, Jason Xu, Jonathan H Sussman, et al.Cell Reports|November 6, 2024
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoNian E Zhou, Su Tang, Xuelin Bian, et al.ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.Leukemia|February 15, 2024
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group ReportN J DelRocco, M L Loh, M J Borowitz, et al.Physical Review Letters|November 9, 2019
Multiple Shape Coexistence in ^{110,112}CdP E Garrett, T R Rodríguez, A Diaz Varela, et al.Journal of Virology|June 5, 2025
Inherited chromosomally integrated human herpesvirus 6: regional variation in prevalence, association with angina, and identification of ancestral viral lineages in two large UK studiesMichael L Wood, Adam J Bell, Robin Young, et al.Blood|March 18, 2025
STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALLJason Xu, Jonathan H Sussman, Austin Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology GroupKaren R Rabin, Meenakshi Devidas, Zhiguo Chen, et al.Blood|April 15, 2017
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology GroupShalini C Reshmi, Richard C Harvey, Kathryn G Roberts, et al.Pageof 218